Exploitation of adaptive evolution in glioma treatment

Area of Science:

• Neuro-oncology
• Cancer Biology
• Evolutionary Medicine

Background:

• Glioblastoma multiforme (GBM) is a highly lethal primary brain tumor.
• Standard treatments offer limited long-term survival, with most patients developing treatment resistance.
• Tumor resistance often arises from adaptive evolution under therapeutic and microenvironmental pressures.

Purpose of the Study:

• To review the concept of adaptive evolution in glioblastoma multiforme.
• To discuss the potential of exploiting adaptive evolution as a novel therapeutic strategy for GBM.
• To explore new treatment paradigms for overcoming glioblastoma resistance.

Main Methods:

• Literature review of studies on glioblastoma treatment resistance.
• Analysis of adaptive evolution mechanisms in cancer.
• Synthesis of current understanding of GBM biology and treatment response.

Main Results:

• Glioblastoma exhibits significant adaptive evolution in response to therapy.
• Treatment resistance is a key factor in GBM lethality.
• Adaptive evolutionary principles offer potential targets for novel therapeutic interventions.

Conclusions:

• Understanding GBM adaptive evolution is crucial for developing effective treatments.
• Exploiting tumor adaptive evolution presents a promising new paradigm for GBM therapy.
• Targeting evolutionary dynamics may overcome treatment resistance in glioblastoma.